Clinical Trial Update: Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF) [NA]

View source ↗

Summary

A clinical trial investigating the impact of short-term treatment with Canacardia-HF (canagliflozin) in conditions including Type 2 diabetes mellitus and heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Canacardia-HF (canagliflozin)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Type2 Diabetes, Heart Failure | NA | Status: WITHDRAWN